Accepted paper Page 1 This article has been accepted for publication and undergone full
peer review but has not been through the copyediting, typesetting, pagination and …

New Drugs Effective in the Systemic Treatment of Hepatocellular Carcinoma Page 1 56 | CliniCal
liver Disease, vOl 14, nO 2, aUGUsT 2019 An Official Learning Resource of AASLD review new …

Hepatocellular carcinoma (HCC) is a dreaded malignancy that every year causes half a
million deaths worldwide. Being an aggressive cancer, its incidence exceeds 700,000 new …

Hepatocellular carcinoma (HCC) is one of the most lethal malignant tumours worldwide. The
mortality-to-incidence ratio is up to 91.6% in many countries, representing the third leading …

Medical therapy for hepatocellular carcinoma (HCC) is an area of active investigation
because fewer than 25% of patients are candidates for curative resection or transplantation …

Liver cancer, mostly hepatocellular carcinoma (HCC), is the second leading cause of cancer
mortality globally. Most patients need at least one systemic therapy at different phases of …

Primary liver cancer is one of the commonest causes of death. Hepatocellular carcinoma
(HCC) accounts for 90% of primary liver cancers. For patients with unresectable or …

Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma Page 1 62 | CliniCal liver
Disease, vOl 14, nO 2, aUGUsT 2019 An Official Learning Resource of AASLD review …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and it is the third leading
cause of cancer-related deaths worldwide. Once diagnosed with the disease, only 30-40 …

Hepatocellular carcinoma (HCC) is one of the more common causes of cancer death
worldwide. It occurs on a background of chronic liver disease or viral hepatitis in the vast …